| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |